Suppr超能文献

相似文献

2
Immunotherapy in non-small cell lung cancer harbouring driver mutations.
Cancer Treat Rev. 2021 May;96:102179. doi: 10.1016/j.ctrv.2021.102179. Epub 2021 Mar 19.
3
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
Jpn J Clin Oncol. 2021 Jan 1;51(1):28-36. doi: 10.1093/jjco/hyaa187.
4
Optimal first-line immune checkpoint inhibitor treatment in lung cancer: how to choose?
Future Oncol. 2022 Feb;18(6):635-638. doi: 10.2217/fon-2021-1348. Epub 2022 Jan 12.
7
Predictive genetic biomarkers in immune checkpoint inhibitors for non-small-cell lung cancer.
Immunotherapy. 2022 Mar;14(4):249-257. doi: 10.2217/imt-2021-0175. Epub 2022 Jan 25.
9
Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer.
Trends Cancer. 2021 May;7(5):410-429. doi: 10.1016/j.trecan.2020.11.005. Epub 2020 Dec 9.
10
Efficacy of immune checkpoint inhibitor therapy in patients with fusion-positive non-small-cell lung cancer.
Immunotherapy. 2021 Aug;13(11):893-904. doi: 10.2217/imt-2021-0035. Epub 2021 Jun 18.

引用本文的文献

1
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.
Cancers (Basel). 2025 Mar 4;17(5):882. doi: 10.3390/cancers17050882.
3
Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment.
PLoS Comput Biol. 2024 May 3;20(5):e1012088. doi: 10.1371/journal.pcbi.1012088. eCollection 2024 May.
4
Mathematical Modeling Support for Lung Cancer Therapy-A Short Review.
Int J Mol Sci. 2023 Sep 25;24(19):14516. doi: 10.3390/ijms241914516.
5
Opportunities and challenges of 5G network technology toward precision medicine.
Clin Transl Sci. 2023 Nov;16(11):2078-2094. doi: 10.1111/cts.13640. Epub 2023 Sep 25.
7
Intracellular Adhesion Molecule-1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8 T Cells.
Adv Sci (Weinh). 2023 Jun;10(17):e2204378. doi: 10.1002/advs.202204378. Epub 2023 Apr 25.
9
mRNA in cancer immunotherapy: beyond a source of antigen.
Mol Cancer. 2021 Mar 3;20(1):48. doi: 10.1186/s12943-021-01329-3.

本文引用的文献

2
Tumor mutational burden in lung cancer: a systematic literature review.
Oncotarget. 2019 Nov 12;10(61):6604-6622. doi: 10.18632/oncotarget.27287.
3
Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chess.
Ann Oncol. 2019 Nov 1;30(11):1690-1691. doi: 10.1093/annonc/mdz297.
4
First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light.
Lung Cancer. 2019 Aug;134:245-253. doi: 10.1016/j.lungcan.2019.06.007. Epub 2019 Jun 19.
5
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
Ann Oncol. 2019 Sep 1;30(9):1448-1459. doi: 10.1093/annonc/mdz196.
8
Computational oncology--mathematical modelling of drug regimens for precision medicine.
Nat Rev Clin Oncol. 2016 Apr;13(4):242-54. doi: 10.1038/nrclinonc.2015.204. Epub 2015 Nov 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验